Edition:
United Kingdom

People: Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,708.00GBp
25 Jun 2019
Change (% chg)

-- (--)
Prev Close
1,708.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,076,817
52-wk High
1,738.50
52-wk Low
1,242.50

Baker, Graham 

Mr. Graham Baker is Chief Financial Officer, Executive Director of the Company. He joined the Board as Chief Financial Officer in March 2017. He is based in London, UK. Career and experience Graham holds an MA degree in Economics from Cambridge University and qualified as a Chartered Accountant and Chartered Tax Adviser with Arthur Andersen. In 1995, he joined AstraZeneca PLC where he worked for 20 years, holding multiple senior roles, including Vice President Finance & Chief Financial Officer, North America (2008–2010), Vice President, Global Financial Services (2010–2013) and Vice President, Finance, International (2013–2015 with responsibility for all emerging markets. Most recently, Graham was Chief Financial Officer of generic pharmaceuticals company Alvogen. Skills and competencies Graham has deep sector knowledge and has had extensive exposure to established and emerging markets which is extremely relevant to his role at Smith & Nephew. He has a strong track record of delivering operational excellence and has relevant experience across major finance roles and geographic markets, leading large teams responsible for significant budgets.

Basic Compensation

Total Annual Compensation, USD 1,764,230
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 212,302
Fiscal Year Total, USD 1,976,530

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --